SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

中国のDNAシークエンシング市場

The Chinese Market for DNA Sequencing

商品番号：SMB-86708
出版社BCC Research
出版年月2025年9月
ページ数82
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

Report Scope

This report provides an overview of the Chinese market for DNA sequencing and analyzes market trends. It includes revenue ($ million) for the base year data for 2024 and estimated data for 2025, and compound annual growth rate (CAGR) forecasts through the end of 2030. The market analyzed by products and services, technology, applications, end-users and provinces. The provinces covered in this study include Beijing, Shanghai, Guangdong and others.

In this report, “China” refers to mainland China and does not include Hong Kong, Macao, or Taiwan. Mainland China has 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Beijing, Shanghai and Guangdong are also discussed in this report.

The report also highlights developments related to venture capital and corporate investments, regulatory trends and enterprise strategies of key firms and potential future opportunities stemming from AI-driven sequences of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis and tariff assessments makes this report a critical resource for stakeholders, investors and policymakers seeking to understand and take advantage of the rapidly developing Chinese DNA sequencing sector. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also analyzes emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking or share of key companies. It also has a dedicated section of company profiles that covers details of leading companies.

Report Includes
– 16 data tables and 40 additional tables
– Overview and an analysis of the Chinese market for DNA sequencing technologies
– Analyses of the Chinese market trends, with revenue data from 2022-2024, estimates for 2025, and projected CAGRs through 2030
– Estimates of the size and revenue prospects for the market, along with a market share analysis by product and service type, technology, application, end user and provinces
– Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
– Insights derived from Porter’s Five Forces model and global supply chain analysis
– Discussion of emerging trends and opportunities in next-generation DNA sequencing technologies and applications in research and clinical markets
– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
– Profiles of the leading companies, including BGI, Novogene Co. Ltd., Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx.

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Technological Advances
Market Dynamics and Growth Factors
Segmental Analysis
Conclusion
Chapter 2 Market Overview
Overview and Market Definition
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Competition in the Industry
Threat of Substitutes
Impact of the U.S. Tariffs
Direct Impact on Global Companies (e.g., Illumina, Thermo Fisher Scientific)
Indirect Impact: Catalyzing Domestic Growth and Self-Sufficiency in China
Impact on Market Structure and Long-Term Dynamics
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Government Investment and National Strategic Initiatives
Innovation and Technological Advances – Making Sequencing Affordable
Growing Demand for Precision Medicine and Oncology Genomics
Market Restraints
High Cost of DNA Sequencing Technologies and Operational Barriers
Regulatory Complexity and Data Privacy Challenges
Market Opportunities
Expansion of Precision Medicine
Growth in Non-invasive Prenatal Testing
Chapter 4 Regulatory Landscape
Chinese DNA Sequencing Industry Regulatory Scenario
Key Regulatory Authorities
Human Genetic Resources (HGR) Regulations
Clinical Use of DNA Sequencing
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Long-Read Sequencing Technologies
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Spatial Genomics and Transcriptomics
Single-Cell DNA Sequencing
Ultra-Low-Input Sequencing
CRISPR-Cas9 and Genome Editing Integration with Sequencing Technologies
Artificial Intelligence (AI) and Machine Learning in DNA Sequencing
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Chinese DNA Sequencing Market Analysis by Product and Service
Instruments and Consumables
Services
Chinese DNA Sequencing Market Analysis, by Technology
Next-Generation Sequencing (NGS)
Third-Generation Sequencing
Sanger Sequencing
Pyrosequencing
Chinese DNA Sequencing Market Analysis, by Application
Biopharma
Microbiology
Agriculture
Chinese DNA Sequencing Market Analysis, by End User
Academic and Research Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Clinical Research
Chinese DNA Sequencing Market Analysis, by Province
Guangdong
Beijing
Shanghai
Other Chinese Regional Markets
Chapter 7 Competitive Landscape
Overview
Domestic Companies
International Companies
Chapter 8 Appendix
Methodology
References
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
ANNOROAD GENE TECHNOLOGY
BERRY GENOMICS
BGI
BURNING ROCK DX
CAPITALBIO TECHNOLOGY CO. LTD.
ILLUMINA INC.
NOVOGENE CO. LTD.
OXFORD NANOPORE TECHNOLOGIES PLC
PACBIO
THERMO FISHER SCIENTIFIC INC.
Emerging Start-ups/Market Disruptors

List of Tables

List of Tables
Summary Table : Chinese Market for DNA Sequencing, by Technology, Through 2030
Table 1 : Chinese Market for DNA Sequencing, by Product and Service, Through 2030
Table 2 : DNA Sequencing Instruments and Consumables Offered by Major Companies
Table 3 : Chinese Market for DNA Sequencing Instruments and Consumables, by Workflow, Through 2030
Table 4 : Chinese Market for DNA Sequencing Services, by Workflow, Through 2030
Table 5 : Chinese Market for DNA Sequencing, by Technology, Through 2030
Table 6 : Chinese Market for DNA Sequencing, by Application, Through 2030
Table 7 : Chinese Market for DNA Sequencing, by End User, Through 2030
Table 8 : Chinese Market for DNA Sequencing, by Province, Through 2030
Table 9 : Leading Chinese DNA Sequencing Companies, 2024
Table 10 : Leading Chinese DNA Sequencing Companies’ Strategic Developments, 2023-2025
Table 11 : Information Sources for this Report
Table 12 : Glossary of Terms Used in the Chinese DNA Sequencing Market
Table 13 : Agilent Technologies Inc.: Company Snapshot
Table 14 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 15 : Agilent Technologies Inc.: Product Portfolio
Table 16 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
Table 17 : Annoroad Gene Technology: Company Snapshot
Table 18 : Annoroad Gene Technology: Product Portfolio
Table 19 : Annoroad Gene Technology: News/Key Developments, 2024
Table 20 : Berry Genomics: Company Snapshot
Table 21 : Berry Genomics: Financial Performance, FY 2023 and 2024
Table 22 : Berry Genomics: Product Portfolio
Table 23 : Berry Genomics: News/Key Developments, 2024-2025
Table 24 : BGI: Company Snapshot
Table 25 : BGI: Financial Performance, FY 2023 and 2024
Table 26 : BGI: Product Portfolio
Table 27 : BGI: News/Key Developments, 2025
Table 28 : Burning Rock Dx: Company Snapshot
Table 29 : Burning Rock Dx: Financial Performance, FY 2022 and 2023
Table 30 : Burning Rock Dx: Product Portfolio
Table 31 : Burning Rock Dx: News/Key Developments, 2023-2024
Table 32 : CapitalBio Technology Co. Ltd.: Company Snapshot
Table 33 : CapitalBio Technology Co. Ltd.: Product Portfolio
Table 34 : CapitalBio Technology Co. Ltd.: News/Key Developments, 2024-2025
Table 35 : Illumina Inc.: Company Snapshot
Table 36 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 37 : Illumina Inc.: Product Portfolio
Table 38 : Illumina Inc.: News/Key Developments, 2023-2024
Table 39 : Novogene Co. Ltd.: Company Snapshot
Table 40 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
Table 41 : Novogene Co. Ltd.: Product Portfolio
Table 42 : Novogene Co. Ltd.: News/Key Developments, 2023-2024
Table 43 : Oxford Nanopore Technologies plc: Company Snapshot
Table 44 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
Table 45 : Oxford Nanopore Technologies plc: Product Portfolio
Table 46 : Oxford Nanopore Technologies plc: News/Key Developments, 2024
Table 47 : PacBio: Company Snapshot
Table 48 : PacBio: Financial Performance, FY 2023 and 2024
Table 49 : PacBio: Product Portfolio
Table 50 : PacBio: News/Key Developments, 2023-2024
Table 51 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 52 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 53 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 54 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
Table 55 : List of Few Emerging Startups in the Chinese market for DNA sequencing

List of Figures

List of Figures
Summary Figure : Chinese Market Shares of DNA Sequencing, by Technology, 2024
Figure 1 : Porter’s Five Forces Analysis of the Chinese DNA Sequencing Market
Figure 2 : Market Dynamics Snapshot of Chinese DNA Sequencing
Figure 3 : Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
Figure 4 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
Figure 5 : Different NGS Technologies and Their Applications
Figure 6 : Chinese Market Shares of DNA Sequencing, by Application, 2024
Figure 7 : Chinese Market Shares of DNA Sequencing, by End User, 2024
Figure 8 : Chinese Market Shares of DNA Sequencing, by Province, 2024
Figure 9 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 10 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 11 : BGI: Revenue Shares, by Business Unit, FY 2024
Figure 12 : BGI: Revenue Shares, by Country/Region, FY 2024
Figure 13 : Burning Rock Dx: Revenue Shares, by Business Segment, FY 2024
Figure 14 : Burning Rock Dx: Revenue Shares, by Country/Region, FY 2024
Figure 15 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 16 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 17 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
Figure 18 : PACBIO: Revenue Shares, by Business Unit, FY 2024
Figure 19 : PACBIO: Revenue Shares, by Country/Region, FY 2024
Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 21 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024

バイオ技術の最新記事8件